Impact of Practice-Based Management of Pulmonary Artery Pressures in 2000 Patients Implanted with the CardioMEMS Sensor

Circulation

Volumn 135, Issue 16, 2017, Pages 1509-1517

  Heywood, J Thomas ^a   Jermyn, Rita ^b   Shavelle, David ^c   Abraham, William T ^d   Bhimaraj, Arvind ^e   Bhatt, Kunjan ^f   Sheikh, Fareed ^g   Eichorn, Eric ^h   Lamba, Sumant ⁱ   Bharmi, Rupinder ^j   Agarwal, Rahul ^j   Kumar, Charisma ^j   Stevenson, Lynne W ^k  

^a SCRIPPS CLINIC   (United States)

^b ST FRANCIS HOSPITAL   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e HOUSTON METHODIST HOSPITAL   (United States)

^f Austin Heart Hospital   (United States)

^g St Rose Dominican Hospitals   (United States)

^h Medical City Dallas   (United States)

ⁱ First Coast Cardiovascular Institute   (United States)

^j ST JUDE MEDICAL   (United States)

^k BRIGHAM AND WOMEN S HOSPITAL   (United States)

more..

Author keywords

heart failure; hemodynamics; pulmonary artery

Indexed keywords

ADULT; AGED; ANONYMISED DATA; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC TEST ACCURACY STUDY; ELECTRODE IMPLANTATION; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; GENERAL PRACTICE; HEART FAILURE; HEMODYNAMIC MONITORING; HUMAN; IMPLANTABLE CARDIAC MONITOR; IMPLANTABLE PULMONARY ARTERY PRESSURE MONITORING SYSTEM; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREDICTIVE VALUE; PRIORITY JOURNAL; PULMONARY ARTERY PRESSURE MONITORING; PULMONARY HYPERTENSION; RECEIVER OPERATING CHARACTERISTIC; REMOTE SENSING; RISK REDUCTION; STUDENT T TEST; TREND STUDY; UNITED STATES; VERY ELDERLY; BLOOD PRESSURE MONITORING; LUNG WEDGE PRESSURE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PULMONARY ARTERY;

AGED; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HUMANS; MALE; PULMONARY ARTERY; PULMONARY WEDGE PRESSURE;

EID: 85014044932     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.026184     Document Type: Article

References (48)

1. Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vadu-ganathan M, Nodari S, Lam CS, Sato N, Shah AN, Gheorghiade M. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63:1123-1133. doi: 10.1016/j. jacc.2013.11.053.
2. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure: the SOLVD Investigators. N Engl J Med. 1991;325:293-302.
3. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001-2007.
4. Cohn JN, Tognoni G; Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001;345:1667-1675. doi: 10.1056/NEJMoa010713.
5. Maggioni AP, Anand I, Gottlieb SO, Latini R, Tognoni G, Cohn JN; Val-HeFT Investigators (Valsartan Heart Failure Trial). Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors. J Am Coll Cardiol. 2002;40:1414-1421.
6. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL; Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651-1658. doi: 10.1056/NEJM200105313442201.
7. Packer M, Poole-Wilson PA, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Rydén L, Thygesen K, Uretsky BF. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure: ATLAS Study Group. Circulation. 1999;100:2312-2318.
8. Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Mi-chelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S; CHARM Investigators and Committees. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003;362:759-766.
9. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palen-sky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709-717. doi: 10.1056/NEJM199909023411001.
10. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardio-verter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237. doi: 10.1056/NEJMoa043399.
11. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchroniza-tion therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150. doi: 10.1056/NEJMoa032423.
12. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kap-penberger L, Tavazzi L; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchroni-zation on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-1549. doi: 10.1056/NEJMoa050496.
13. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883. doi: 10.1056/NEJMoa013474.
14. Blecker S, Paul M, Taksler G, Ogedegbe G, Katz S. Heart failure- associated hospitalizations in the United States. J Am Coll Cardiol. 2013;61:1259-1267. doi: 10.1016/j.jacc.2012.12.038.
15. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, Ikonomidis JS, Khavjou O, Konstam MA, Mad-dox TM, Nichol G, Pham M, Piña IL, Trogdon JG; American Heart Association Advocacy Coordinating Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Stroke Council. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6:606-619. doi: 10.1161/ HHF.0b013e318291329a.
16. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cush-man M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133:e38-e360.
17. Center for Medicare and Medicaid Services. 100% MEDPAR In-patient Hospital National Data for Fiscal Year 2011. http://www. cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/MedicareFeeforSvcPartsAB/Downloads/DRG11.pdf. Accessed March 10, 2017.
18. Cotter G, Metra M, Milo-Cotter O, Dittrich HC, Gheorghiade M. Fluid overload in acute heart failure: re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail. 2008;10:165-169. doi: 10.1016/j.ejheart.2008.01.007.
19. Gheorghiade M, Filippatos G, De Luca L, Burnett J. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med. 2006;119(suppl 1):S3-S10. doi: 10.1016/j.amjmed.2006.09.011.
20. Kato M, Stevenson LW, Palardy M, Campbell PM, May CW, Lak-dawala NK, Stewart G, Nohria A, Rogers JG, Heywood JT, Gheo-rghiade M, Lewis EF, Mi X, Setoguchi S. The worst symptom as defined by patients during heart failure hospitalization: implications for response to therapy. J Card Fail. 2012;18:524-533. doi: 10.1016/j.cardfail.2012.04.012.
21. Metra M, Dei Cas L, Bristow MR. The pathophysiology of acute heart failure: it is a lot about fluid accumulation. Am Heart J. 2008;155:1-5. doi: 10.1016/j.ahj.2007.10.011.
22. Schiff GD, Fung S, Speroff T, McNutt RA. Decompensated heart failure: symptoms, patterns of onset, and contributing factors. Am J Med. 2003;114:625-630.
23. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJV, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WHW, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:e240-e327. doi: 10.1161/CIR.0b013e31829e8776.
24. Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z, Phillips CO, Hodshon BV, Cooper LS, Krumholz HM. Telemonitor-ing in patients with heart failure. N Engl J Med. 2010;363:2301-2309. doi: 10.1056/NEJMoa1010029.
25. Cleland JG, Louis AA, Rigby AS, Janssens U, Balk AH; TEN-HMS Investigators. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol. 2005;45:1654-1664. doi: 10.1016/j.jacc.2005.01.050.
26. Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Böhm M, Boll H, Baumann G, Honold M, Koehler K, Gelbrich G, Kirwan BA, Anker SD; Telemedical Interventional Monitoring in Heart Failure Investigators. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the Telemedical Interventional Monitoring in Heart Failure Study. Circulation. 2011;123:1873-1880. doi: 10.1161/ CIRCULATIONAHA.111.018473.
27. Ong MK, Romano PS, Edgington S, Aronow HU, Auerbach AD, Black JT, De Marco T, Escarce JJ, Evangelista LS, Hanna B, Ganiats TG, Greenberg BH, Greenfield S, Kaplan SH, Kimchi A, Liu H, Lombardo D, Mangione CM, Sadeghi B, Sadeghi B, Sar-rafzadeh M, Tong K, Fonarow GC; Better Effectiveness After Transition-Heart Failure (BEAT-HF) Research Group. Effectiveness of remote patient monitoring after discharge of hospitalized patients with heart failure: the Better Effectiveness After Transition-Heart Failure (BEAT-HF) randomized clinical trial. JAMA Intern Med. 2016;176:310-318. doi: 10.1001/jamain-ternmed.2015.7712.
28. Adamson PB, Ginn G, Anker SD, Bourge RC, Abraham WT. Remote haemodynamic-guided care for patients with chronic heart failure: a meta-analysis of completed trials. Eur J Heart Fail. 2017;19:426-433. doi: 10.1002/ejhf.638.
29. van Veldhuisen DJ, Braunschweig F, Conraads V, Ford I, Cowie MR, Jondeau G, Kautzner J, Aguilera RM, Lunati M, Yu CM, Gerritse B, Borggrefe M; DOT-HF Investigators. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation. 2011;124:1719-1726. doi: 10.1161/ CIRCULATIONAHA.111.043042.
30. Abraham WT, Stevenson LW, Bourge RC, Lindenfeld JA, Bauman JG, Adamson PB; CHAMPION Trial Study Group. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. Lancet. 2016;387:453-461. doi: 10.1016/ S0140-6736(15)00723-0.
31. Drazner MH, Rame JE, Stevenson LW, Dries DL. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med. 2001;345:574-581. doi: 10.1056/NEJMoa010641.
32. Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hos-pitalizations predict mortality in the community population with heart failure. Am Heart J. 2007;154:260-266. doi: 10.1016/j. ahj.2007.01.041.
33. Adamson PB. Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: new insights from continuous monitoring devices. Curr Heart Fail Rep. 2009;6:287-292.
34. Zile MR, Bennett TD, St John Sutton M, Cho YK, Adamson PB, Aaron MF, Aranda JM Jr, Abraham WT, Smart FW, Stevenson LW, Kueffer FJ, Bourge RC. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation. 2008;118:1433-1441. doi: 10.1161/CIRCULA-TIONAHA.108.783910.
35. Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, Strickland W, Neelagaru S, Raval N, Krueger S, Weiner S, Shavelle D, Jeffries B, Yadav JS; CHAMPION Trial Study Group. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377:658-666. doi: 10.1016/S0140-6736(11)60101-3.
36. Abraham WT, Adamson PB, Hasan A, Bourge RC, Pamboukian SV, Aaron MF, Raval NY. Safety and accuracy of a wireless pulmonary artery pressure monitoring system in patients with heart failure. Am Heart J. 2011;161:558-566. doi: 10.1016/j. ahj.2010.10.041.
37. Adamson PB, Magalski A, Braunschweig F, Böhm M, Reynolds D, Steinhaus D, Luby A, Linde C, Ryden L, Cremers B, Takle T, Bennett T. Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol. 2003;41:565-571.
38. Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A, Zile MR, Smith AL, Smart FW, O'Shaughnessy MA, Jes-sup ML, Sparks B, Naftel DL, Stevenson LW; COMPASS-HF Study Group. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol. 2008;51:1073-1079. doi: 10.1016/j.jacc.2007.10.061.
39. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC): developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891-975. doi: 10.1002/ejhf.592.
40. Adamson PB, Abraham WT, Aaron M, Aranda JM Jr, Bourge RC, Smith A, Stevenson LW, Bauman JG, Yadav JS. CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system. J Card Fail. 2011;17:3-10. doi: 10.1016/j.cardfail.2010.08.002.
41. Adamson PB, Abraham WT, Bourge RC, Costanzo MR, Hasan A, Yadav C, Henderson J, Cowart P, Stevenson LW. Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction. Circ Heart Fail. 2014;7:935-944. doi: 10.1161/CIRCHEARTFAIL-URE.113.001229.
42. Benza RL, Raina A, Abraham WT, Adamson PB, Lindenfeld J, Miller AB, Bourge RC, Bauman J, Yadav J. Pulmonary hypertension related to left heart disease: insight from a wireless implantable hemodynamic monitor. J Heart Lung Transplant. 2015;34:329-337. doi: 10.1016/j.healun.2014.04.014.
43. Krahnke JS, Abraham WT, Adamson PB, Bourge RC, Bauman J, Ginn G, Martinez FJ, Criner GJ; Champion Trial Study Group. Heart failure and respiratory hospitalizations are reduced in patients with heart failure and chronic obstructive pulmonary disease with the use of an implantable pulmonary artery pressure monitoring device. J Card Fail. 2015;21:240-249. doi: 10.1016/j.cardfail.2014.12.008.
44. Costanzo MR, Stevenson LW, Adamson PB, Desai AS, Heywood JT, Bourge RC, Bauman J, Abraham WT. Interventions linked to decreased heart failure hospitalizations during ambulatory pulmonary artery pressure monitoring. JACC Heart Fail. 2016;4:333-344. doi: 10.1016/j.jchf.2015.11.011.
45. Ritzema J, Troughton R, Melton I, Crozier I, Doughty R, Krum H, Walton A, Adamson P, Kar S, Shah PK, Richards M, Eigler NL, Whiting JS, Haas GJ, Heywood JT, Frampton CM, Abraham WT; Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOMEOSTASIS) Study Group. Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure. Circulation. 2010;121:1086-1095. doi: 10.1161/ CIRCULATIONAHA.108.800490.
46. Stevenson LW, Zile M, Bennett TD, Kueffer FJ, Jessup ML, Adamson P, Abraham WT, Manda V, Bourge RC. Chronic ambulatory intracardiac pressures and future heart failure events. Circ Heart Fail. 2010;3:580-587. doi: 10.1161/CIRCHEARTFAILURE.109.923300.
47. Zile MR, Bennett TD, El Hajj S, Kueffer FJ, Baicu CF, Abraham WT, Bourge RC, Warner Stevenson L. Intracardiac pressures measured using an implantable hemodynamic monitor: relationship to mortality in patients with chronic heart failure. Circ Heart Fail. 2017;10;e003594. doi: 10.1161/CIRCHEARTFAILURE.116.003594.
48. Adamson PB, Abraham WT Stevenson LW, Desai AS, Lindenfeld J, Bourge RC, Bauman J. Pulmonary artery pressure-guided heart failure management reduces 30-day readmissions. Circ Heart Fail. 2016;9.e002600. doi: 10.1161/CIRCHEARTFAILURE. 115.002600.